IMNM

Immunome, Inc. - Common Stock (IMNM)

About Immunome, Inc. - Common Stock (IMNM)

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Details

Daily high

$25.26

Daily low

$24.19

Price at open

$24.63

52 Week High

$30.06

52 Week Low

$9.36

Market cap

2.7B

Dividend yield

Volume

1.2M

Avg. volume

1.1M

P/E ratio

-9.49

Immunome, Inc. - Common Stock News